Karriereverlauf von John Harlan
Ehemalige bekannte Positionen von John Harlan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01.01.2004 | 01.01.2004 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - | - |
| Cytel Corp. | Direktor/Vorstandsmitglied | - | - |
CisThera, Inc.
 CisThera, Inc. Pharmaceuticals: MajorHealth Technology CisThera, Inc. operates as a biopharmaceutical company. It develops therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. The company was founded by John Harlan and is headquartered in Kirkland, WA. | Gründer | - | - |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
CisThera, Inc.
CisThera, Inc. Pharmaceuticals: MajorHealth Technology CisThera, Inc. operates as a biopharmaceutical company. It develops therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. The company was founded by John Harlan and is headquartered in Kirkland, WA. | Health Technology |
| Cytel Corp. | |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- John Harlan
- Erfahrung
